Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Wise vs Wide: A National, Multicenter, Prospective, Randomized and Controlled, Parallel Group, Non-inferiority Study to Compare Single- vs Two-staged Excisions of Thin Melanoma

NCT06363591 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT06363591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06363591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Wise vs Wide: A National, Multicenter, Prospective, Randomized and Controlled, Parallel Group, Non-inferiority Study to Compare Single- vs Two-staged Excisions of Thin Melanoma
Lead sponsor
Vastra Gotaland Region
Phase
Not applicable
Overall status
Recruiting
Start date
January 22, 2025
Completion date
December 31, 2039
Enrollment
2,486 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma